Willow Biosciences is at the forefront of synthetic biology, specializing in precision fermentation to produce natural ingredients for various markets, including health and wellness, food and beverage, and personal care. Their proprietary FutureGrown™ platform enables the rapid transition of fermentation processes from lab-scale to commercial-scale production, allowing for the efficient creation of sustainable ingredients. This platform is designed to meet the increasing demand for functional ingredients while simplifying the supply chain compared to traditional plant-based production methods. The company leverages a network of global manufacturing partners to ensure reliable capacity and scalability, catering to both large and small production needs.

The team at Willow Biosciences comprises a diverse group of experts, including strain engineers, bioinformaticians, fermentation scientists, and chemists, all of whom contribute to the company's innovative approach. With a strong emphasis on sustainability, Willow aims to challenge conventional production methods and deliver safe, eco-friendly ingredients. Their commitment to scientific excellence is reflected in their experienced leadership and a robust understanding of market dynamics, positioning them as a trusted partner in the biotechnology sector. Through their advanced technologies and collaborative efforts, Willow Biosciences is dedicated to creating high-value molecules that benefit both consumers and the environment.

Canada

Willow Biosciences is a biotechnology company focused on the development of a disruptive bio-based process for the production of high purity cannabinoids. Its Burnaby lab houses state-of-the-art molecular biology, tissue culture, plant cultivation and analytical chemistry capabilities focused on correlating the physical and chemical characteristics of cannabis plants with their unique genetic makeup.

Willow Biosciences

Company Details